RemeGen
688331118.920.57% ( -0.68 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: RemeGen(688331) the Revenue is 656.21 M (+24.76%);the EBIT is -22.08 M (+90.18%);the EPS is 0.58 (+226.1%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.66B24.76%
----
----
EBIT
-0.02B90.18%
----
----
EPS
0.58226.09%
----
----
Upcoming earnings report - FY2026 Semi-Annual Earning Release
Available dateAug 25, 2026
Estimate Revenue3.343 B
Estimate EBIT1.752 B
Estimate EPS--
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf